Viewing nowRosuvastatin Calcium 5mg
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 201405050 · Approved 2014.10.30 · Insurance code 657805460
Improvement of hyperlipidemia; inhibition of atherosclerosis progression; reduction of cardiovascular disease risk
This medication acts as an adjunct to diet and exercise in patients with primary hypercholesterolemia and mixed dyslipidemia who are not adequately controlled by diet and exercise alone. It is also used in conjunction with diet and other therapies to lower cholesterol levels in patients with homozygous familial hypercholesterolemia. It helps lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia to target levels, thereby slowing the progression of atherosclerosis. It is used as a dietary adjunct in pediatric patients with heterozygous familial hypercholesterolemia aged 10 to 17 years. Additionally, it supports treatment in patients with primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and the need for vascular interventions in middle-aged and older adults at high risk for cardiovascular diseases. This medication is effective in improving cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 mg per day. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with use in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Age 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, individuals who are allergic to this medication, those with severely impaired liver function, patients with muscle disorders, those with severely impaired kidney function, and pregnant or breastfeeding women should not take this medication. Furthermore, high doses of this medication are contraindicated in patients at high risk of muscle problems. This medication contains lactose, so individuals with genetic issues like lactose intolerance should avoid it. It is important to regularly monitor liver function and muscle condition while taking this medication. Patients who consume alcohol heavily or have a history of liver disease should exercise extra caution, and those with hypothyroidism or other specific diseases should receive treatment first. If symptoms such as muscle pain or weakness occur, immediate notification of healthcare personnel is advised, and the medication may be discontinued if necessary. Taking this medication with certain drugs may increase blood concentrations, increasing the risk of muscle damage, so it is essential to consult a physician before combining it with other medications. In particular, it is advisable not to combine it with fibrate class drugs. Women who are pregnant or may become pregnant should ensure they use appropriate contraceptive measures before taking this medication and should avoid it during pregnancy. Breastfeeding mothers should also avoid this medication as it may be passed into breast milk. In case of overdose, there is no specific antidote, so treatment should be symptom-based and liver function and muscle enzyme levels should be monitored regularly. Dizziness may occur during treatment with this medication, so caution is required when driving or operating machinery. Finally, this medication may show higher blood concentrations in Asians, which may necessitate dosage adjustments.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, hypersensitivity drug reaction syndrome with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.